Recent Finacing
Recent Raise
Piqur Therapeutics is a clinical-stage pharmaceutical company developing PI3K and mTOR inhibitors for oncology, advancing lead PQR309 in clinical studies and progressing follow-up compounds into preclinical and clinical testing.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor